...
首页> 外文期刊>Journal of cellular and molecular medicine. >D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke
【24h】

D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke

机译:D1受体介导的内源性TPA上调有助于急性缺血性卒中后血脑屏障损伤有助于血脑屏障损伤

获取原文

摘要

Blood‐brain barrier (BBB) integrity injury within the thrombolytic time window is becoming a critical target to reduce haemorrhage transformation (HT). We have previously reported that BBB damage was initially damaged in non‐infarcted striatum after acute ischaemia stroke. However, the underlying mechanism is not clear. Since acute ischaemic stroke could induce a significant increase of dopamine release in striatum, in current study, our aim is to investigate the role of dopamine receptor signal pathway in BBB integrity injury after acute ischaemia using rat middle cerebral artery occlusion model. Our data showed that 2‐h ischaemia induced a significant increase of endogenous tissue plasminogen activator (tPA) in BBB injury area and intra‐striatum infusion of tPA inhibitor neuroserpin, significantly alleviated 2‐h ischaemia‐induced BBB injury. In addition, intra‐striatum infusion of D1 receptor antagonist SCH23390 significantly decreased ischaemia‐induced upregulation of endogenous tPA, accompanied by decrease of BBB injury and occludin degradation. More important, inhibition of hypoxia‐inducible factor‐1 alpha with inhibitor YC‐1 significantly decreased 2‐h ischaemia‐induced endogenous tPA upregulation and BBB injury. Taken together, our data demonstrate that acute ischaemia disrupted BBB through activation of endogenous tPA via HIF‐1α upregulation, thus representing a new therapeutic target for protecting BBB after acute ischaemic stroke.
机译:血液脑屏障(BBB)溶栓时间窗口的完整性损伤正在成为减少出血转化(HT)的关键目标。我们此前报道,在急性患者中风后,BBB损伤最初在非梗死的纹状体中受损。但是,潜在机制尚不清楚。由于急性缺血性卒中可以诱导纹状体中的多巴胺释放,在目前的研究中,我们的目的是研究多巴胺受体信号途径在使用大鼠中脑动脉闭塞模型急性患者急性患者后BBB完整性损伤的作用。我们的数据表明,2-H次数诱导BBB损伤面积中内源组织纤溶酶原激活剂(TPA)的显着增加,以及TPA抑制剂神经皮林的脊髓内输注,显着缓解了2-H isChaemia诱导的BBB损伤。此外,D1受体拮抗剂SCH23390的晶体内输注诱导的内源TPA诱导的内源TPA诱导的逐渐降低,伴随着BBB损伤和呼吸抑制蛋白降解的降低。更重要的是,抑制缺氧诱导因子1α与抑制剂YC-1的抑制显着降低了2-H iscaemia诱导的内源TPA上调和BBB损伤。我们的数据一起携带,通过HIF-1α上调,通过活化内源TPA激活急性胰蛋白酶破坏BBB,从而代表急性缺血性卒中后保护BBB的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号